Neuroimmunology
Natalizumab and PML in MS
Jan. 13, 2026
Professor of Neurology
University of Chicago
Editorial Board Member since 2000: Neuroimmunology
Clinical Interests: Neuromyelitis optica, multiple sclerosis, tetanus, neuroimmunology
Contributor Disclosures
Dr. Reder of the University of Chicago received honorariums from Genentech, Genzyme, and TG Therapeutics for service on advisory boards and as a consultant and stock options from NKMax America for advisory work and an unrestricted lab research grant from BMS.